All Type of News
Government to expand health insurance coverage for serious diseases
The Ministry of Health and Welfare announced it has expanded the conventional health insurance allowance to three items, such as Zeffix tablet, Vancomycin injection and Ambisome injection, including anticancer agents ...
Abbott Korea launched 'iDECIDE' anti-obesity campaign
Abbott Korea, which has marketed its weight loss drug Reductil since 2001, has announced that it is starting a new anti-obesity online campaign entitled 'iDECIDE', with an aim to publicize the importance of obese pati...
Kim Kyung-ho becomes GSK Korea managing directorGSK Korea, a sales arm of UK-based GSK group, said on August 1 that it has appointed Kim Kyung-ho, a former development director of Korea Green Cross Corporation, as the company...
|
Mr. Hyeon Dong-wook nominated CEO of Baxter Korea.Mr. Hyeon Dong-wook, the former president of Metronic Korea, was nominated the CEO of Baxter Korea, a bio-tech company as of Aug. 2.
He studied at California University majo...
|
50 leading OTC products analyzed
The combined market share of Korea's 50 leading OTC drugs for the fist six months accounted for 37.58 percent, up 36.95 percent in January, and SK Pharm's Trast patch 48mg had the highest cumulative six-month ...
Government policy to focus on drug reclassification and DUR activation.
The government and the ruling Uri party discussed the sales ban on the PPA contained remedies and the future administrative and drug safety measures focusing on the drug reclassification and the enforcement of the DUR...
Industries looking for best PPA substitutes.
The yearly 300 billion won size of the cold remedy markets seemed to be rapidly transformed with other alternatives contained non-PPA ingredients like pseudo-ephedrin and herbal preparations, especially the combined r...
Government vows to investigate potential harmful substances
Amid mounting public outcry over the belated ban of the Korea Food and Drug Administration on phenylpropanolamine (PPA)-containing cold remedies, the government unveiled its plan to make efforts to remove PPA-containi...
PPA-containing medicines ban having little impact to six Korea drug makers in Korea Stock Exchange
Overall, the share prices of six pharmaceutical firms producing phenylpropanolamine (PPA) based cold remedies showed little sign of plunge between July 30 to August 5, despite the recent jitters over PPA drugs...
Domestic cold remedy makers rushing to recall PPA-containing preparations
With the recent announcement of the Korea Food and Drug Administration that it has banned production and sales of 167 cough and cold remedies containing phenylpropanolamine (PPA), an ingredient that may cause hemorrha...
